Allergy Therapeutics plc
AGYTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $295,093 | $198,112 | $226,116 | $21,389 |
| - Cash | $17,558 | $21,676 | $12,715 | $13,522 |
| + Debt | $60,089 | $44,519 | $30,988 | $9,850 |
| Enterprise Value | $337,624 | $220,955 | $244,389 | $17,717 |
| Revenue | $41,534 | $34,030 | $21,627 | $33,572 |
| % Growth | 22.1% | 57.3% | -35.6% | – |
| Gross Profit | $13,636 | $20,862 | $9,217 | $20,520 |
| % Margin | 32.8% | 61.3% | 42.6% | 61.1% |
| EBITDA | -$36,249 | -$4,151 | -$22,814 | -$9,352 |
| % Margin | -87.3% | -12.2% | -105.5% | -27.9% |
| Net Income | -$39,876 | -$11,085 | -$24,565 | -$15,651 |
| % Margin | -96% | -32.6% | -113.6% | -46.6% |
| EPS Diluted | -0.008 | -0.002 | -0.005 | -0.006 |
| % Growth | -265.2% | 55.8% | 10.3% | – |
| Operating Cash Flow | -$28,950 | -$7,704 | -$21,364 | -$10,774 |
| Capital Expenditures | -$2,389 | -$1,524 | -$1,536 | -$1,865 |
| Free Cash Flow | -$31,338 | -$9,228 | -$22,900 | -$12,639 |